Search

Your search keyword '"Hideki, Araoka"' showing total 3 results
Start Over Author "Hideki, Araoka" Publisher the japanese association for infectious diseases
3 results on '"Hideki, Araoka"'

1. The Clinical Significance of Running Two Sets of Blood Cultures in the Patients with Allogeneic Hematopoietic Stem Cell Transplantation Under Fluoroquinolone Prophylaxis

Author

Shuichi Taniguchi, Hideki Araoka, Akiko Yoneyama, Masahiro Abe, and Muneyoshi Kimura

Subjects
medicine.diagnostic_test, business.industry, medicine.medical_treatment, Immunology, medicine, Clinical significance, Blood culture, General Medicine, Hematopoietic stem cell transplantation, medicine.disease, business, Febrile neutropenia
Published
2020
Full Text
View/download PDF

2. A Case of Sepsis Caused by Multidrug-resistant Neutropenic-phase Pseudomonas aeruginosa Treated Successfully with Antibiotic Combination Therapy

Author

Atsushi Wake, Shuichi Taniguchi, Shinsuke Takagi, Hideki Araoka, Masaru Baba, Naofumi Matsuno, Keita Tatsushima, and Akiko Yoneyama

Subjects
Male, medicine.drug_class, Antibiotics, medicine.disease_cause, Meropenem, Microbiology, Aztreonam, chemistry.chemical_compound, Sepsis, polycyclic compounds, medicine, Humans, Pseudomonas Infections, Amikacin, business.industry, Pseudomonas aeruginosa, General Medicine, Middle Aged, biochemical phenomena, metabolism, and nutrition, bacterial infections and mycoses, medicine.disease, Drug Resistance, Multiple, Anti-Bacterial Agents, Treatment Outcome, chemistry, Bacteremia, Linezolid, Colistin, Vancomycin, Drug Therapy, Combination, business, medicine.drug
Abstract

Multidrug-resistant Pseudomonas aeruginosa (MDRP), defined as Pseudomonas aeruginosa resistant to aminoglycosides, carbapenems, and fluoroquinolones, has emerged as an increasingly problematic cause of hospital-acquired infection. With parenteral colistin unavailable in Japan, effective antimicrobial options are severely limited. We report a case of MDRP bacteremia successfully treated with antibiotic combination therapy screened by a 'Break-point Checkerboard Plate'. A 54-year-old man with malignant lymphoma who became febrile 9 days after a recent course of chemotherapy had a neutrophil count of 176/microL. Treatment with meropenem and vancomycin was ineffective and high fever persisted. Methicillin-resistant Staphylococcus aureus (MRSA) and MDRP were isolated from blood culture and combination therapy with aztreonam and amikacin was selected for MDRP based on 'Break-point Checkerboard Plate' results. Linezolid was used for MRSA. The patient recovered successfully from MDRP and MRSA sepsis.

Published
2008
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results